Hospital, Health & Pharma

Hamdard Laboratories starts proof of concept clinical trial for its two immunity boosting medicines, to prevent infection of COVID-19 in high-risk subjects

New Delhi, September 07, 2020 (GPN): Hamdard Laboratories (Medicine Division), a progressive research-based health and wellness organization, announced that it has received all the regulatory approvals to begin the proof of concept clinical trial for its…


Importance of Nutrition and Eye Care for Kids during the Pandemic and increased Online classes: By Dr. Anitha C Kamarthy, M.S. Sr. Cataract & Glaucoma Surgeon, MaxiVision Super Specialty Eye Hospital, Hyderabad

Nutrition month (Sept 2020) to beat the Eye strain with the intake of healthy & robust food? – Author, Dr.Anitha C Kamarthy, M.S. Sr. Cataract & Glaucoma Surgeon, MaxiVision Super Specialty Eye Hospital, Hyderabad. MUMBAI, 6…


In India COVID-19 Vaccine ‘COVAXIN’ Phase 2 Trials underway, USA trial 3 to be completed before November whereas WHO say Vaccine will be made possible only by Mid 2021; Russia Claims their ‘Sputnik V’ Vaccine is Authorised for Use amid Phase 3 Trials

NATIONAL, 6 SEPTEMBER, 2020 (GPN) : In USA some of the Top vaccine developers, including Pfizer Inc, Johnson & Johnson and Moderna Inc, plan to issue a public pledge not to seek government approval until their…


PIB NEWS UPDATE ON PMO AND MINISTRY’S FOR 1st WEEK OF SEPTEMBER

MUMBAI, 06 SEPTEMBER, 2020 (GPN): Prime Minister’s Office Hon. President and Prime Minister to address the Governors’ Conference on NEP-2020 Ministry of Agriculture & Farmers Welfare Railways announce increase in frequency of Devlali-Muzaffarpur Kisan Rail…




CETAPHIL BABY LAUNCHES SOAP-FREE SYNDET BAR; ORCHESTRATES FIRST-OF- ITS-KIND DIGITAL CAMPAIGN WITH ZEE5 & SAUMYA TANDON

Mumbai, India, September 04, 2020 (GPN): ZEE5, the Entertainment Super App of India, has been a preferred platform for bespoke premium content consumption for millions of Indians so far. In a first-of-its-kind collaboration, Galderma India Pvt Ltd…



Nanotechnology in Theranosticsand Nutraceuticals intervention for GI cancers – By Dr. Anubhab Mukherjee, Ph.D Principal Scientist | Esperer Onco Nutrition Pvt. Ltd. | R&D

MUMBAI, 4 SEPTEMBER, 2020 (GPN):  Gastrointestinal (GI) cancer, the 5th most common malignancy involving epigenetic, genetic, and environmental factors withhigh rate of human demise,still remains a daunting challengeto be circumvented.Of many, MicrosatelliteInstability (MSI) triggered by DNA…